ES2530370T3 - Células del epitelio pigmentario de la retina derivadas de células madre - Google Patents

Células del epitelio pigmentario de la retina derivadas de células madre Download PDF

Info

Publication number
ES2530370T3
ES2530370T3 ES12181140T ES12181140T ES2530370T3 ES 2530370 T3 ES2530370 T3 ES 2530370T3 ES 12181140 T ES12181140 T ES 12181140T ES 12181140 T ES12181140 T ES 12181140T ES 2530370 T3 ES2530370 T3 ES 2530370T3
Authority
ES
Spain
Prior art keywords
cells
retinal pigment
pigment epithelial
stem cells
epithelial cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12181140T
Other languages
English (en)
Other versions
ES2530370T5 (es
ES2530370T8 (es
Inventor
Masha Idelson
Ruslana Alper-Pinus
Alex Obolensky
Eyal Banin
Benjamin Reubinoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Original Assignee
Hadasit Medical Research Services and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2530370(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hadasit Medical Research Services and Development Co filed Critical Hadasit Medical Research Services and Development Co
Publication of ES2530370T3 publication Critical patent/ES2530370T3/es
Publication of ES2530370T8 publication Critical patent/ES2530370T8/es
Application granted granted Critical
Publication of ES2530370T5 publication Critical patent/ES2530370T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Un método para producir células del epitelio pigmentario de la retina (RPE), comprendiendo el método: a. cultivar células madre pluripotentes hu 5 manas en un medio suplementado con nicotinamida para generar células en diferenciación; y b. cultivar dichas células en diferenciación en un medio que comprende uno o más miembros de la superfamilia del factor de crecimiento transformante β (TGF β) y nicotinamida, produciendo de este modo células RPE.
ES12181140.0T 2007-04-18 2008-04-27 Células del epitelio pigmentario de la retina derivadas de células madre Active ES2530370T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90781807P 2007-04-18 2007-04-18
US907818P 2007-04-18

Publications (3)

Publication Number Publication Date
ES2530370T3 true ES2530370T3 (es) 2015-03-02
ES2530370T8 ES2530370T8 (es) 2016-06-24
ES2530370T5 ES2530370T5 (es) 2018-05-28

Family

ID=39666210

Family Applications (2)

Application Number Title Priority Date Filing Date
ES08738258.6T Active ES2527444T5 (es) 2007-04-18 2008-04-27 Células del epitelio pigmentario de la retina derivadas de células madre
ES12181140.0T Active ES2530370T5 (es) 2007-04-18 2008-04-27 Células del epitelio pigmentario de la retina derivadas de células madre

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES08738258.6T Active ES2527444T5 (es) 2007-04-18 2008-04-27 Células del epitelio pigmentario de la retina derivadas de células madre

Country Status (9)

Country Link
US (3) US8956866B2 (es)
EP (4) EP3640326A1 (es)
JP (1) JP5395058B2 (es)
CN (2) CN103555654B (es)
AU (1) AU2008242106B2 (es)
CA (1) CA2684460C (es)
ES (2) ES2527444T5 (es)
IL (2) IL225163B (es)
WO (1) WO2008129554A1 (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937099A1 (en) 2004-01-23 2005-08-04 Astellas Institute For Regenerative Medicine Improved modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
US8597947B2 (en) 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
WO2006070370A2 (en) * 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
CA2684460C (en) 2007-04-18 2017-01-03 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
EP2209888B1 (en) * 2007-10-12 2019-12-04 Astellas Institute for Regenerative Medicine Improved methods of producing rpe cells and compositions of rpe cells
JP5951254B2 (ja) * 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
JPWO2009148170A1 (ja) 2008-06-06 2011-11-04 独立行政法人理化学研究所 幹細胞の培養方法
CN101580816B (zh) * 2009-04-23 2012-02-29 中国科学院广州生物医药与健康研究院 诱导多能性干细胞快速高效产生的新型无血清培养基以及使用其的方法
EP3553170B1 (en) * 2009-08-24 2024-02-14 Wisconsin Alumni Research Foundation Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
ES2509567T3 (es) 2009-08-28 2014-10-17 Cellular Dynamics International, Inc. Identificación de variación genética en tejidos afectados
RU2409663C1 (ru) * 2009-10-14 2011-01-20 Российская Федерация, от имени которой выступает Федеральное Агентство по науке и инновациям Способ получения дедифференцированных клеток ретинального пигментного эпителия глаза взрослого человека
US10793830B2 (en) 2009-11-05 2020-10-06 Riken Method for producing retinal tissue in vitro
IL281453B (en) * 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
WO2012149480A2 (en) * 2011-04-29 2012-11-01 University Of Southern California Systems and methods for in vitro and in vivo imaging of cells on a substrate
AU2011279250B2 (en) 2010-07-12 2014-12-04 California Institute Of Technology Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
EP3875599B1 (en) * 2010-07-23 2024-12-11 Astellas Institute for Regenerative Medicine Methods for detection of rare subpopulations of cells and highly purified compositions of cells
FI20106354A0 (fi) * 2010-12-20 2010-12-20 Suomen Punainen Risti Veripalvelu Menetelmä ihmisen retinan pigmentti-epiteelisolujen valmistamiseksi
US9732319B2 (en) 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
WO2012149468A2 (en) 2011-04-29 2012-11-01 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
JP6067232B2 (ja) * 2011-11-25 2017-01-25 住友化学株式会社 網膜層特異的神経細胞を製造する方法
JP5985208B2 (ja) * 2011-11-25 2016-09-06 住友化学株式会社 網膜組織の製造方法
JP5985207B2 (ja) * 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
US10973854B2 (en) 2011-11-25 2021-04-13 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
JP5985209B2 (ja) * 2011-11-25 2016-09-06 住友化学株式会社 眼杯様構造体の製造方法
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
AU2013216382B2 (en) * 2012-01-31 2018-08-02 Hadasit Medical Research Services And Development Ltd. Methods of selecting retinal pigmented epithelial cells
RU2486603C1 (ru) * 2012-04-11 2013-06-27 Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН (ИБР РАН) Способ моделирования тканевой структуры сетчатки глаза человека
CN103627669A (zh) * 2012-08-22 2014-03-12 复旦大学 一种诱导人多能干细胞分化为视网膜前体细胞的方法
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
CA2914286A1 (en) * 2013-04-03 2014-10-09 Tampereen Yliopisto Methods and media for differentiating eye cells
US11274277B2 (en) 2013-08-06 2022-03-15 Riken Method for producing anterior eye segment tissue
CN105683366B (zh) 2013-08-23 2020-11-06 住友化学株式会社 用于制备视网膜组织和视网膜相关细胞的方法
AU2014332856B2 (en) * 2013-10-09 2020-03-05 Healios K.K. Method of producing retinal pigment epithelial cell
CA2930092C (en) * 2013-11-11 2024-03-12 Sumitomo Chemical Company, Limited Method for producing retinal pigment epithelial cells
US20150148383A1 (en) * 2013-11-22 2015-05-28 Regenerative Research Foundation Methods for Inhibiting or Reversing Epiretinal Membrane Formation
AU2014363032A1 (en) 2013-12-11 2016-06-09 Pfizer Limited Method for producing retinal pigment epithelial cells
CN120536341A (zh) 2014-03-04 2025-08-26 菲特治疗公司 改良的重编程方法和细胞培养平台
US20170080030A1 (en) * 2014-03-17 2017-03-23 University Of Virginia Patent Foundation Compositions and methods for treating retinopathy
WO2015175504A1 (en) * 2014-05-12 2015-11-19 The Johns Hopkins University Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors
AU2015336454B2 (en) * 2014-10-24 2021-04-29 Racthera Co., Ltd. Production method for retinal tissue
CN113564123B (zh) 2014-10-24 2024-11-15 住友制药株式会社 神经组织的制备方法
EP3233093B1 (en) 2014-12-18 2022-06-29 Sorbonne Universite Transgenic rpe cells overexpressing otx2 for the treatment of retinal degeneration
CA2972700A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases
AU2015373050B2 (en) 2014-12-30 2022-09-29 Cell Cure Neurosciences Ltd. RPE cell populations and methods of generating same
US20180011092A1 (en) 2014-12-30 2018-01-11 Cell Cure Neurosciences Ltd. Assessing retinal pigment epithelial cell populations
EP3328995B1 (en) 2015-07-29 2021-03-31 Hadasit Medical Research Services And Development Large scale production of retinal pigment epithelial cells
EP3331995A1 (en) * 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
CN108138144A (zh) 2015-08-05 2018-06-08 细胞治疗神经科学有限公司 视网膜色素上皮细胞的制备
JP6884354B2 (ja) 2015-09-08 2021-06-09 大日本住友製薬株式会社 網膜組織の製造方法
CN105112368B (zh) * 2015-09-30 2018-09-21 奥思达干细胞有限公司 一种治疗视网膜变性的干细胞制剂及其使用方法
CN117737124A (zh) 2015-10-16 2024-03-22 菲特治疗公司 用于诱导和维护基态多能性的平台
HUE070900T2 (hu) 2015-10-26 2025-07-28 Cell Cure Neurosciences Ltd Eljárás retinális pigmentepitélium-sejtek elõállítására
CH711966A2 (it) * 2015-12-23 2017-06-30 Pinelli Roberto Cellule staminali retinali.
JP6995314B2 (ja) 2016-04-22 2022-02-21 大日本住友製薬株式会社 網膜組織の製造法
MX2019006576A (es) 2016-12-07 2019-08-21 Mayo Found Medical Education & Res Metodos y materiales para usar soportes de fibrina para trasplante de epitelio de pigmento retiniano.
CN106754718A (zh) * 2016-12-19 2017-05-31 胡其锐 一种人胚胎干细胞快速定向分化至视网膜色素上皮细胞的方法
WO2018146679A2 (en) * 2017-02-08 2018-08-16 Hadasit Medical Research Services And Development Ltd. Photoreceptor cells for the treatment of retinal diseases
US20200085882A1 (en) 2017-03-16 2020-03-19 Lineage Cell Therapeutics, Inc. Methods for measuring therapeutic effects of retinal disease therapies
AU2018282179B2 (en) 2017-06-05 2024-03-07 Mayo Foundation For Medical Education And Research Methods and materials for culturing, proliferating, and differentiating stem cells
CN108728413A (zh) * 2017-06-13 2018-11-02 中山大学中山眼科中心 一种人多能干细胞来源人视网膜色素上皮细胞的制备和扩增培养方法
US11168301B2 (en) 2017-10-05 2021-11-09 Eyestem Research Private Limited Method for producing photoreceptor cells, retinal pigmented epithelial cells, and retinal organoids
BR112020013238A2 (pt) 2017-12-29 2020-12-01 Cell Cure Neurosciences Ltd. composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana
US11814652B2 (en) 2018-03-22 2023-11-14 Oriental Yeast Co., Ltd. Pluripotent stem cell differentiation-promoting agent
CN108531443A (zh) * 2018-04-04 2018-09-14 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 小分子诱导多能性干细胞分化为视网膜色素上皮细胞的方法
CN110205283B (zh) * 2018-04-18 2021-04-23 浙江大学 一种诱导人羊膜上皮细胞向视网膜色素上皮细胞分化的方法及其应用
WO2019204817A1 (en) 2018-04-20 2019-10-24 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
EP3969570A1 (en) * 2019-05-15 2022-03-23 Novo Nordisk A/S Methods for obtaining eye field progenitor cells from human pluripotent stem cells
EP3754014A1 (en) 2019-06-21 2020-12-23 Centre d'Etude des Cellules Souches (CECS) Automated method for preparing retinal pigment epithelium cells
CA3184790A1 (en) * 2020-05-25 2021-12-02 Lineage Cell Therapeutics, Inc. Methods and compositions for treating retinal diseases and conditions
KR20230019453A (ko) * 2020-05-29 2023-02-08 후지필름 셀룰러 다이내믹스, 인코포레이티드 망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법
JP2024522608A (ja) 2021-06-09 2024-06-21 リネージ セル セラピューティクス インコーポレイテッド 網膜の疾患および症状を処置するための方法および組成物
CA3225834A1 (en) 2021-07-28 2023-02-02 Lineage Cell Therapeutics, Inc. Expansion of retinal pigment epithelium cells
CN119384700A (zh) 2022-04-15 2025-01-28 艾斯本神经科学公司 细胞分化状态的分类方法和分化细胞的相关组合物
CN115840045B (zh) * 2023-02-23 2023-04-28 中国农业大学 一种猪胚胎期毛囊基板前体细胞的鉴定方法及其应用
WO2025083169A1 (en) 2023-10-17 2025-04-24 Tenpoint Therapeutics Limited Combination of a vegf inhibitor and a complement pathway inhibitor for treating ocular disorders
KR20260118423A (ko) * 2023-10-30 2026-07-30 더 잭슨 래보라토리 망막 질환을 위한 세포 요법
CN117467607A (zh) * 2023-12-19 2024-01-30 南京艾尔普再生医学科技有限公司 一种获取稳定性能rpe细胞的方法、制剂、药物组合物及试剂
CN119709618B (zh) * 2024-12-25 2025-10-28 电子科技大学附属医院·四川省人民医院 一种从iPSC分化的细胞中分选成熟RPE细胞的方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG49267A1 (en) 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
US5750342A (en) * 1990-06-11 1998-05-12 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
TW209224B (es) * 1991-05-27 1993-07-11 Yoshitomi Pharmaceutical
US6045791A (en) 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
DE4219250A1 (de) * 1992-06-12 1993-12-16 Behringwerke Ag Serum-freies Zellkulturmedium
JP3490447B2 (ja) * 1993-04-30 2004-01-26 フォトジェネシス インコーポレイテッド 網膜色素上皮移植
US5755785A (en) 1994-08-12 1998-05-26 The University Of South Florida Sutureless corneal transplantation method
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5941250A (en) 1996-11-21 1999-08-24 University Of Louisville Research Foundation Inc. Retinal tissue implantation method
GB9715584D0 (en) 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
JP3663990B2 (ja) 1999-08-31 2005-06-22 不二製油株式会社 含気チョコレート及びその製造法
GB0001930D0 (en) 2000-01-27 2000-03-22 Novartis Ag Organic compounds
EP1294855A4 (en) 2000-06-20 2004-09-15 Es Cell Int Pte Ltd METHOD FOR CONTROLLING THE DIFFERENTIATION OF EMBRYONIC STEM CELLS (ES CELLS) BY CULTURE OF ES CELLS IN THE PRESENCE OF BMP-2 TRACK ANTAGONISTS
WO2002060875A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
WO2003060082A2 (en) * 2002-01-14 2003-07-24 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
US20050019718A1 (en) 2003-07-22 2005-01-27 Hanson G. Herbert Orthodontic devices for use with arch wires
US7794704B2 (en) * 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
CA2937099A1 (en) * 2004-01-23 2005-08-04 Astellas Institute For Regenerative Medicine Improved modalities for the treatment of degenerative diseases of the retina
DE102004048640A1 (de) * 2004-10-04 2006-04-06 Otmar Fahrion Kette
JP2006113175A (ja) * 2004-10-13 2006-04-27 Konica Minolta Opto Inc 光学フィルム、偏光板及び表示装置
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
CA2684460C (en) 2007-04-18 2017-01-03 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
US8611382B2 (en) 2009-02-25 2013-12-17 Koninklijke Philips N.V. Output power stabilization for laser diodes using the photon-cooling dependent laser voltage
EP3047017B1 (en) * 2013-10-09 2025-09-10 The Regents of the University of California Methods of mammalian retinal stem cell production and applications

Also Published As

Publication number Publication date
CN101688178B (zh) 2013-12-04
IL256587A (en) 2018-02-28
CA2684460A1 (en) 2008-10-30
EP2554661B2 (en) 2018-02-21
IL256587B (en) 2020-04-30
WO2008129554A1 (en) 2008-10-30
EP3640326A1 (en) 2020-04-22
EP2147094B1 (en) 2014-10-08
HK1211619A1 (en) 2016-05-27
EP2554661A1 (en) 2013-02-06
IL225163B (en) 2018-01-31
ES2527444T5 (es) 2018-05-17
HK1140791A1 (en) 2010-10-22
ES2530370T5 (es) 2018-05-28
JP2010524457A (ja) 2010-07-22
EP2554661B1 (en) 2014-11-19
CA2684460C (en) 2017-01-03
US20110027333A1 (en) 2011-02-03
ES2530370T8 (es) 2016-06-24
ES2527444T8 (es) 2016-06-22
CN101688178A (zh) 2010-03-31
AU2008242106A1 (en) 2008-10-30
US20150125506A1 (en) 2015-05-07
HK1179647A1 (en) 2013-10-04
AU2008242106B2 (en) 2013-05-16
HK1191377A1 (zh) 2014-07-25
EP2886646A1 (en) 2015-06-24
EP2147094A1 (en) 2010-01-27
CN103555654B (zh) 2016-04-20
ES2527444T3 (es) 2015-01-23
US8956866B2 (en) 2015-02-17
US20150118749A1 (en) 2015-04-30
EP2147094B2 (en) 2018-02-21
CN103555654A (zh) 2014-02-05
EP2886646B1 (en) 2019-08-14
JP5395058B2 (ja) 2014-01-22

Similar Documents

Publication Publication Date Title
ES2527444T3 (es) Células del epitelio pigmentario de la retina derivadas de células madre
AU2015256601B2 (en) Replacement heart valves and their methods of use and manufacture
EP2279247A4 (en) STEM CELLS OF THE RETINAL PIGMENTARY EPITHELIUM
MY192843A (en) Antibodies specific for tgf-beta
EP3546568A3 (en) Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins ln-511, ln-521 and ln-221
BR112015003839A2 (pt) método para produzir lâmina de células do epitélio pigmentar da retina
SI2274419T1 (sl) Postopek izdelave lasnih mikromešičkov in novih papil in njihova uporaba za in vitro teste in in vivo implantacijo
JP2018502575A5 (es)
WO2013063305A3 (en) Directed cardiomyocyte differentiation of stem cells
WO2014113704A3 (en) Enhanced differentiation of mesenchymal stem cells
Arena et al. β-glucans and synbiotic foods
FI20106354A0 (fi) Menetelmä ihmisen retinan pigmentti-epiteelisolujen valmistamiseksi
Brunelli et al. PERIOGLASS AND ITS OSTEOGENIC POTENTIAL
Niada et al. Study of porcine adipose-derived stem cells for orthopaedic preclinical models
Tirelli Characterization of human erythroblasts produced in vitro using HEMA culture
Mattioli et al. AMNIOTIC MEMBRANE DERIVED CELLS FOR THE ASSESSMENT OF SCAFFOLD BIOCOMPATIBILITY
Lopa et al. Adherence of human adipose-derived stem cells (hASCs) variably increases a prompt osteogenic differentiation
Cilurzo et al. Silk fibroin/PEG composite scaffolds for tissue engineering
Zanoletti Biotechnological strategies to improve the quality of enriched cereal foods
Musolino et al. TISSUE ENGINEERING OF HEART VALVES–IN VITRO EXPANSION OF ENDOTHELIAL CELL BY DIFFERENT VESSELS REVEALS THE BETTER AUTOLOGOUS CELLULAR SOURCE FOR TISSUE REPLACEMENT
Giacomelli et al. New insights on the human bone-marrow and gingival mesenchymal stem cell responses to senescence induction
Canullo et al. Cell growth on Titanium disks treated by Plasma of Argon Experimental study
Castellari The Insane Poet on the Stage: Friedrich Hölderlin in Twentieth-Century Theatre
Plavšić et al. Wisdom and health in adulthood
Bellucci et al. Bioceramic scaffolds: where materials science meets life–Part I